Fennec Pharmaceuticals Inc Share Price Today: Live Updates & Key Insights

Fennec Pharmaceuticals Inc share price today is $7.34, up -4.31%. The stock opened at $7.595 against the previous close of $7.65, with an intraday high of $7.62 and low of $7.345.

Fennec Pharmaceuticals Inc Share Price Chart

Fennec Pharmaceuticals Inc

us-stock
To Invest in {{usstockname}}
us-stock

Fennec Pharmaceuticals Inc Share Price Performance

$7.34 -0.0431(-4.31%) FENC at 23 Mar 2026 01:01 PM Biotechnology
Lowest Today 7.345
Highest Today 7.62
Today’s Open 7.595
Prev. Close 7.65
52 Week High 9.92
52 Week Low 4.68
Day’s Range: Low 7.345 High 7.62
52-Week Range: Low 4.68 High 9.92
1 day return -
1 Week return -5.76
1 month return -18.15
3 month return -4.42
6 month return -15.9
1 year return +11.53
3 year return -3.22
5 year return +5.9
10 year return -

Fennec Pharmaceuticals Inc Institutional Holdings

Southpoint Capital Advisors LP 8.04

Rosalind Advisors, Inc. 7.65

Solas Capital Management LLC 7.50

AIGH Capital Management, LLC 4.63

BlackRock Inc 3.55

Vanguard Group Inc 3.13

Vanguard Total Stock Mkt Idx Inv 2.56

Awm Investment Company Inc 2.08

iShares Russell 2000 ETF 1.60

State Street Corp 1.00

TANG CAPITAL MANAGEMENT LLC 0.98

Geode Capital Management, LLC 0.87

Morgan Stanley - Brokerage Accounts 0.68

Fidelity Small Cap Index 0.67

Apis Capital Advisors, LLC 0.60

Citadel Advisors Llc 0.58

Harbert Fund Advisors Inc 0.52

iShares Russell 2000 Value ETF 0.42

Gendell Jeffrey L 0.41

Northern Trust Corp 0.38

Marshall Wace Asset Management Ltd 0.37

State St Russell Sm/Mid Cp® Indx SL Cl I 0.37

Lion Point Capital, LP 0.36

Vanguard Russell 2000 ETF 0.33

Bridgeway Capital Management, LLC 0.24

Bridgeway Ultra-Small Company 0.24

State St Russell Sm Cap® Indx SL Cl I 0.20

iShares Micro-Cap ETF 0.18

Charles Schwab Investment Management Inc 0.17

Schwab Small Cap Index 0.17

iShares Russell 2000 Growth ETF 0.15

NT R2000 Index Fund - NL 0.15

NT R2000 Index Fund - DC - NL - 3 0.12

Russell 2500™ Index Fund F 0.12

iShares Russell 2000 Small-Cap Idx Instl 0.11

Stt Strt SPDR® Russell2000 US SmCapETF 0.09

EQ/2000 Managed Volatility IB 0.08

Spartan Small Cap Index Pool K 0.08

Nuveen Small Cap Blend Idx R6 0.07

Vanguard Instl Ttl Stck Mkt Idx Tr 0.07

Fennec Pharmaceuticals Inc Market Status

Strong Buy: 3

Buy: 2

Hold: 0

Sell: 0

Strong Sell: 0

Fennec Pharmaceuticals Inc Fundamentals

Market Cap 250.00 M

PB Ratio 57.9258

PE Ratio 0.0

Enterprise Value 248.40 M

Total Assets 44.95 M

Volume 574001

Fennec Pharmaceuticals Inc Company Financials

Annual Revenue FY23:13052000 13.1M, FY22:1535000 1.5M, FY21:0 0.0M, FY20:170000 0.2M, FY19:0 0.0M

Annual Profit FY23:12392000 12.4M, FY22:1449000 1.4M, FY21:null 0.0M, FY20:170000 0.2M, FY19:null 0.0M

Annual Net worth FY23:-20220000 -20.2M, FY22:-24839000 -24.8M, FY21:-17456000 -17.5M, FY20:-17922000 -17.9M, FY19:-12460000 -12.5M

Quarterly Revenue Q3/2025:12462000 12.5M, Q2/2025:9652000 9.7M, Q1/2025:8751000 8.8M, Q3/2024:6974000 7.0M, Q2/2024:7262000 7.3M

Quarterly Profit Q3/2025:11802000 11.8M, Q2/2025:8685000 8.7M, Q1/2025:8378000 8.4M, Q3/2024:5617000 5.6M, Q2/2024:6654000 6.7M

Quarterly Net worth Q3/2025:-638000 -0.6M, Q2/2025:-3152000 -3.2M, Q1/2025:-1165000 -1.2M, Q3/2024:-5735000 -5.7M, Q2/2024:-5553000 -5.6M

About Fennec Pharmaceuticals Inc & investment objective

Company Information Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. Fennec Pharmaceuticals Inc. has collaboration with Tampa General Hospital Foundation, Inc. for evaluation of clinical utility of sodium thiosulfate injection in reducing the risk of ototoxicity in adolescent, young adult, and adult cancer patients receiving cisplatin-based treatment. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.

Organisation Biotechnology

Employees 32

Industry Biotechnology

CEO Mr. Jeffrey S. Hackman

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Fennec Pharmaceuticals Inc FAQs

What is the share price of Fennec Pharmaceuticals Inc today?

The current share price of Fennec Pharmaceuticals Inc is $7.34.

Can I buy Fennec Pharmaceuticals Inc shares in India?

Yes, Indian investors can buy Fennec Pharmaceuticals Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Fennec Pharmaceuticals Inc shares in India?

You can easily invest in Fennec Pharmaceuticals Inc shares from India by:

Can I buy fractional shares of Fennec Pharmaceuticals Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Fennec Pharmaceuticals Inc?

Fennec Pharmaceuticals Inc has a market cap of $250.00 M.

In which sector does Fennec Pharmaceuticals Inc belong?

Fennec Pharmaceuticals Inc operates in the Biotechnology sector.

What documents are required to invest in Fennec Pharmaceuticals Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Fennec Pharmaceuticals Inc?

The PE ratio of Fennec Pharmaceuticals Inc is N/A and the PB ratio is 57.93.